Want to see HK:2493 full AI Analyst Report?
Mabwell (Shanghai) Bioscience Co., Ltd. Class H (2493) Financial Statements
Mabwell (Shanghai) Bioscience Co., Ltd. Class H Financial Overview
Mabwell (Shanghai) Bioscience Co., Ltd. Class H's market cap is currently $13.86B. The company's EPS TTM is $-2.36; its P/E ratio is -6.54; Mabwell (Shanghai) Bioscience Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 662.52M | $ 199.78M | $ 127.84M | $ 27.73M | $ 15.96M |
| Gross Profit | $ 598.05M | $ 170.83M | $ 126.47M | $ 27.66M | $ -72.92M |
| Operating Income | $ -955.32M | $ -1.04B | $ -1.05B | ― | $ -785.47M |
| EBITDA | $ -647.88M | $ -844.97M | $ -937.63M | $ -858.54M | $ -699.62M |
| Net Income | $ -969.33M | $ -1.04B | $ -1.05B | $ -955.23M | $ -756.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.53B | $ 1.20B | $ 1.67B | $ 2.55B | $ 96.37M |
| Total Assets | $ 4.56B | $ 4.28B | $ 4.46B | $ 4.62B | $ 1.59B |
| Total Debt | $ 2.60B | $ 2.07B | $ 1.26B | $ 752.83M | $ 333.98M |
| Net Debt | $ 1.07B | $ 878.39M | $ -386.81M | $ -1.74B | $ 237.61M |
| Total Liabilities | $ 4.02B | $ 2.72B | $ 1.88B | $ 1.11B | $ 574.15M |
| Stockholders' Equity | $ 349.51M | $ 1.57B | $ 2.58B | $ 3.52B | $ 1.01B |
| Cash Flow | |||||
| Free Cash Flow | $ -447.93M | $ -1.29B | $ -1.28B | $ -1.26B | $ -624.47M |
| Operating Cash Flow | $ -290.22M | $ -956.44M | $ -782.73M | $ -719.17M | $ -410.56M |
| Investing Cash Flow | $ -199.31M | $ -291.55M | $ -509.62M | $ -602.80M | $ 7.77M |
| Financing Cash Flow | $ 791.92M | $ 831.70M | $ 444.94M | $ 3.72B | $ 195.65M |
Currency in CNY
